HCPCS J1325
Injection, epoprostenol, 0.5 mg
HCPCS Information
- HCPCS Code: J1325
- The Healthcare Common Procedure Coding System (HCPCS) is a set of unique alphanumeric codes used to report medical procedures and services to healthcare programs like Medicare and Medicaid. HCPCS codes are used in conjunction with NDC codes for billing and medical documentation puporses. For instance, HCPCS J1325 identifies the type of service or supply used while any of the 11 NDC codes below could be used to specify the exact drug used.
- Short Description
- Epoprostenol injection
- Long Description
- Injection, epoprostenol, 0.5 mg
- Pricing Indicator
- Drugs
- Multiple Pricing Indicator
- Not applicable as HCPCS priced under one methodology
- Coverage Description
- Special coverage instructions apply
- BETOS Type of Service
- Other drugs
- Medicare Payment Limit
- $16.20
- Medicare Co-Insurance Percentage
- 20.000%
- HCPCS Classification
- List of HCPCS codes for: Drugs Administered Other Than Oral Method, Chemotherapy Drugs (J-codes)
HCPCS Crossover to NDC Codes
The NDC codes below allow precise billing based on the specific manufacturer and medication used:
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0173-0517 | Flolan | Epoprostenol Sodium | Injection, Powder, Lyophilized, For Solution | Intravenous | Glaxosmithkline Llc | ACTIVE | |
| 0173-0519 | Flolan | Epoprostenol Sodium | Injection, Powder, Lyophilized, For Solution | Intravenous | Glaxosmithkline Llc | ACTIVE | |
| 0703-1985 | Epoprostenol Sodium | Teva Parenteral Medicines, Inc. | |||||
| 0703-1995 | Epoprostenol Sodium | Teva Parenteral Medicines, Inc. | |||||
| 62756-059 | Epoprostenol | Epoprostenol | Injection, Powder, Lyophilized, For Solution | Intravenous | Sun Pharmaceutical Industries, Inc. | ACTIVE | |
| 62756-060 | Epoprostenol | Epoprostenol | Injection, Powder, Lyophilized, For Solution | Intravenous | Sun Pharmaceutical Industries, Inc. | ACTIVE | |
| 66215-401 | Veletri | Actelion Pharmaceuticals Us, Inc. | |||||
| 66215-402 | Veletri | Epoprostenol | Injection, Powder, Lyophilized, For Solution | Intravenous | Actelion Pharmaceuticals Us, Inc. | ACTIVE | |
| 66215-403 | Veletri | Epoprostenol | Injection, Powder, Lyophilized, For Solution | Intravenous | Actelion Pharmaceuticals Us, Inc. | ACTIVE | |
| 67457-587 | Epoprostenol | Epoprostenol | Injection, Powder, Lyophilized, For Solution | Intravenous | Mylan Institutional Llc | ACTIVE | |
| 67457-588 | Epoprostenol | Epoprostenol | Injection, Powder, Lyophilized, For Solution | Intravenous | Mylan Institutional Llc | ACTIVE |
